UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 825, ~~2015~~2016

SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware Delaware		001-34465 001-31441		20-1764048 23-2872718
(State or other jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of principal executive offices) (Zip Code)

(717) 972-1100

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 75.0107 ~~Regulation~~Submission FDof ~~Disclosure~~Matters to a Vote of Security Holders.

OnThe ~~April 8,~~annual ~~2015,~~meeting MJof ~~Acquisition~~stockholders ~~Corporation,~~(the a“Annual ~~joint~~Meeting”) ~~venture~~of ~~that~~ Select Medical Holdings Corporation (the “Company”) ~~has~~was ~~created~~held ~~with~~on ~~Welsh, Carson, Anderson~~April ~~& Stowe XII~~25, L2016.~~P.,~~ At ~~launched~~the aAnnual ~~financing~~Meeting, ~~transaction intended to provide debt financing to fund a portion of~~ the ~~purchase~~Company’s ~~price~~stockholders ~~for~~approved ~~its~~four ~~previously announced acquisition of Concentra Inc~~proposals. ~~(“Concentra”).~~ The ~~purchase~~proposals ~~price~~below ~~for~~are ~~Concentra~~described ofin ~~$1.055~~the ~~billion represents approximately 8.3 times Concentra~~Company’s ~~2014~~definitive ~~Adjusted~~proxy ~~EBITDA~~statement ~~after~~dated ~~giving~~March 3, ~~effect to expected synergies~~2016. MJThe ~~Acquisition~~results ~~Corporation~~are isas ~~expecting to raise approximately $650 million of debt financing.~~follows:

~~The~~Proposal ~~information~~1: inThe ~~this~~Election ~~Current Report on Form 8-K is being furnished solely to satisfy the requirements~~ of ~~Regulation~~Three ~~FD and shall not be deemed to be “filed” for purposes of Section~~Class 18I ofDirectors ~~the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject~~ to the ~~liabilities~~Board of ~~that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.~~Directors

Cautionary Note Regarding Forward-Looking Statements

Name	Votes For	Votes Against	Abstentions	Broker Non-Votes
Russell L. Carson	119,059,777	1,746,279	16,306	5,129,033
James S. Ely III	118,880,881	1,924,806	16,675	5,129,033
William H. Frist	110,682,391	10,124,853	15,118	5,129,033

~~Except~~Proposal ~~for historical information, all other information in this Form 8~~2: Non-KBinding ~~consists~~Advisory ofVote ~~forward-looking~~on ~~statements. These forward-looking statements involve a number of risks, uncertainties and other factors, including~~ the ~~expected~~Compensation ~~synergies which may result from the proposed acquisition~~ of ~~Concentra by MJ Acquisition Corporation, which may cause~~ the actual results to be materially different from those expressed or implied in the forward-looking statements. There can be no assurance that the financing referenced above will be completed as described herein or at all. Other important factors are discussed under the caption “Forward-Looking Statements” in the Company’s ~~Form 10-K~~Named ~~Annual~~Executive Report for the year ended December 31, 2014 and in subsequent filings made prior to or after the date hereof. The Company does not intend to review or revise any particular forward-looking statement in light of future events.Officers

Votes For		Votes Against		Abstentions		Broker Non-Votes
102,119,756		18,039,495		663,111		5,129,033

~~SIGNATURE~~Proposal 3: Approval of the Select Medical Holdings Corporation 2016 Equity Incentive Plan

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

Votes For		Votes Against		Abstentions		Broker Non-Votes
117,851,277		2,945,849		25,236		5,129,033

	SELECT MEDICAL HOLDINGS CORPORATION
	SELECT MEDICAL CORPORATION
Date: April 8, 2015	By:	/s/ Michael E. Tarvin
		Michael E. Tarvin
		Executive Vice President, General Counsel and Secretary

Proposal 4: Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2016

Votes For		Votes Against		Abstentions		Broker Non-Votes
125,419,095		497,930		34,370		0

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

	SELECT MEDICAL HOLDINGS CORPORATION
	SELECT MEDICAL CORPORATION


Date: April 27, 2016	By:	/s/ Michael E. Tarvin
		Michael E. Tarvin
		Executive Vice President, General Counsel and Secretary

Filing Compare · SELECT MEDICAL CORP